Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2010-2-5
pubmed:abstractText
To assess the clinical feasibility of utilizing the presence of perihepatic lymphadenopathy, seen on ultrasound, as a marker of response to antiviral treatment in patients with hepatitis C virus (HCV)-related liver disease.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1473-5687
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
22
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
257-63
pubmed:meshHeading
pubmed-meshheading:19177027-Adult, pubmed-meshheading:19177027-Aged, pubmed-meshheading:19177027-Antiviral Agents, pubmed-meshheading:19177027-Biopsy, pubmed-meshheading:19177027-Drug Monitoring, pubmed-meshheading:19177027-Drug Therapy, Combination, pubmed-meshheading:19177027-Feasibility Studies, pubmed-meshheading:19177027-Female, pubmed-meshheading:19177027-Hepacivirus, pubmed-meshheading:19177027-Hepatitis C, pubmed-meshheading:19177027-Humans, pubmed-meshheading:19177027-Interferons, pubmed-meshheading:19177027-Liver, pubmed-meshheading:19177027-Lymph Nodes, pubmed-meshheading:19177027-Lymphatic Diseases, pubmed-meshheading:19177027-Male, pubmed-meshheading:19177027-Middle Aged, pubmed-meshheading:19177027-Predictive Value of Tests, pubmed-meshheading:19177027-Prospective Studies, pubmed-meshheading:19177027-RNA, Viral, pubmed-meshheading:19177027-Ribavirin, pubmed-meshheading:19177027-Time Factors, pubmed-meshheading:19177027-Treatment Outcome, pubmed-meshheading:19177027-Viral Load
pubmed:year
2010
pubmed:articleTitle
Perihepatic lymph nodes as markers of disease response in patients with hepatitis C-related liver disease: a prospective clinical evaluation.
pubmed:affiliation
Liver Unit, Division of Medicine A, St Mary's Hospital Campus, Imperial College London, London, UK.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't